Shareholders' Equity / (Deficit) - Additional Information (Details) $ / shares in Units, $ in Thousands |
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
8 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
|
Feb. 12, 2021
$ / shares
shares
|
Feb. 10, 2021
USD ($)
$ / shares
shares
|
Feb. 09, 2021
USD ($)
$ / shares
shares
|
Feb. 08, 2021
$ / shares
shares
|
Feb. 03, 2021
$ / shares
shares
|
Oct. 31, 2020
$ / shares
shares
|
Oct. 27, 2020
USD ($)
$ / shares
shares
|
Jul. 02, 2020
$ / shares
shares
|
Jun. 05, 2020
$ / shares
shares
|
Jun. 03, 2020
USD ($)
$ / shares
shares
|
Jun. 30, 2020
USD ($)
$ / shares
shares
|
Sep. 30, 2021
USD ($)
$ / shares
shares
|
Sep. 30, 2021
USD ($)
Vote
$ / shares
shares
|
Dec. 31, 2020
USD ($)
$ / shares
shares
|
Jan. 28, 2021
$ / shares
shares
|
Jun. 10, 2020
$ / shares
shares
|
Apr. 27, 2018
$ / shares
shares
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, shares issued |
|
|
|
|
|
|
|
|
|
|
|
182,775,282
|
182,775,282
|
49,431,028
|
|
|
|
Ordinary shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
$ 0.01
|
$ 0.01
|
$ 0.01
|
$ 0.01
|
|
Proceeds from registered direct offerings, net of transaction costs | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 500
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
380,000
|
380,000
|
|
|
|
|
Ordinary shares, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
300,000,000
|
300,000,000
|
150,000,000
|
150,000,000
|
100,000,000
|
|
Number of vote per common share | Vote |
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
Common stock rights and preferences |
|
|
|
|
|
|
|
|
|
|
|
|
The holders of ordinary shares currently have no preemptive or other subscription rights, and there are no redemption or sinking fund provisions with respect to such shares
|
|
|
|
|
Undesignated preferred shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
$ 0.01
|
$ 0.01
|
|
|
|
Undesignated preferred shares, authorized |
|
|
|
|
|
|
|
|
|
|
|
100,000,000
|
100,000,000
|
100,000,000
|
|
|
|
Undesignated preferred shares issued |
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
0
|
|
|
|
Undesignated Preferred Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Undesignated preferred shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
$ 0.01
|
|
|
|
|
Undesignated preferred shares, authorized |
|
|
|
|
|
|
|
|
|
|
|
100,000,000
|
100,000,000
|
|
|
|
|
Designated Preferred Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Undesignated preferred shares issued |
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
0
|
|
|
|
Silicon Valley Bank and Life Sciences Fund II LLC | Series B Convertible Preferred Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
19,890
|
19,890
|
|
|
|
19,890
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 18.85
|
$ 18.85
|
|
|
|
$ 18.85
|
Exchangeable Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, shares issued |
|
|
|
|
|
|
|
|
|
|
|
53,888,331
|
53,888,331
|
|
|
|
|
Aggregate principal amount of exchangeable notes | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 39,200
|
|
|
|
|
|
Aggregate principal amount | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 12,600
|
$ 12,600
|
|
|
|
|
Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
19,890
|
19,890
|
|
|
|
19,890
|
June 3 SPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
$ 0.01
|
|
|
|
|
February Registered Direct Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, shares issued |
|
|
17,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, par value | $ / shares |
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share | $ / shares |
|
|
$ 2.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate gross proceeds from ordinary shares | $ |
|
|
$ 35,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from registered direct offerings, net of transaction costs | $ |
|
|
$ 32,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering closing date |
|
|
Feb. 12, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 3 Offering | June 3 SPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, shares issued |
|
|
|
|
|
|
|
|
|
2,971,770
|
|
|
|
|
|
|
|
Ordinary shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
Offering price per share | $ / shares |
|
|
|
|
|
|
|
|
|
$ 1.6825
|
|
|
|
|
|
|
|
Aggregate gross proceeds from ordinary shares | $ |
|
|
|
|
|
|
|
|
|
$ 5,000
|
|
|
|
|
|
|
|
Proceeds from registered direct offerings, net of transaction costs | $ |
|
|
|
|
|
|
|
|
|
$ 4,300
|
|
|
|
|
|
|
|
Warrants closing date |
|
|
|
|
|
|
|
|
|
Jun. 05, 2020
|
|
|
|
|
|
|
|
June 30 Offering | June 30 SPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, shares issued |
|
|
|
|
|
|
|
|
|
|
3,372,686
|
|
|
|
|
|
|
Ordinary shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
Offering price per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 1.4825
|
|
|
|
|
|
|
Aggregate gross proceeds from ordinary shares | $ |
|
|
|
|
|
|
|
|
|
|
$ 5,000
|
|
|
|
|
|
|
Proceeds from registered direct offerings, net of transaction costs | $ |
|
|
|
|
|
|
|
|
|
|
$ 4,200
|
|
|
|
|
|
|
Warrants closing date |
|
|
|
|
|
|
|
|
|
|
Jul. 02, 2020
|
|
|
|
|
|
|
October Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, shares issued |
|
|
|
|
|
|
15,511,537
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, par value | $ / shares |
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
$ 0.01
|
$ 0.01
|
|
|
|
|
Aggregate gross proceeds from ordinary shares | $ |
|
|
|
|
|
|
$ 17,400
|
|
|
|
|
|
|
|
|
|
|
Proceeds from registered direct offerings, net of transaction costs | $ |
|
|
|
|
|
|
$ 15,500
|
|
|
|
|
|
$ 13,900
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
1,884,615
|
|
|
|
|
|
20,890,516
|
20,890,516
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
|
|
|
|
$ 0.8125
|
$ 0.65
|
|
|
|
|
|
|
|
|
|
|
Warrants expiry date |
|
|
|
|
|
Oct. 22, 2025
|
Oct. 27, 2025
|
|
|
|
|
|
|
|
|
|
|
Percentage of ordinary shares issued to purchase warrants |
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
October Offering | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
20,192,307
|
|
|
|
|
|
|
|
|
|
|
October Offering | Pre-Funded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share | $ / shares |
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
Proceeds from registered direct offerings, net of transaction costs | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 110
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
11,411,539
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
|
|
|
|
|
$ 0.64
|
|
|
|
|
|
|
|
|
|
|
October Offering | Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share | $ / shares |
|
|
|
|
|
|
$ 0.65
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
20,192,307
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
|
|
|
|
|
$ 0.65
|
|
|
|
|
|
|
|
|
|
|
February Underwritten Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
$ 1.4375
|
|
$ 1.4375
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering closing date |
|
Feb. 10, 2021
|
|
Feb. 08, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional ordinary shares that can be purchased by underwriter |
|
5,217,391
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiry date |
|
Feb. 03, 2026
|
|
Feb. 03, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of ordinary shares issued to purchase warrants |
|
7.00%
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February Underwritten Offering | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
365,217
|
|
2,434,783
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February Underwritten Offering | Underwriting Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, shares issued |
|
|
|
|
34,782,609
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, par value | $ / shares |
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share | $ / shares |
|
|
|
|
$ 1.15
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering closing date |
|
|
|
|
Feb. 08, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
February Underwritten Offering | Pursuant to the Underwriting Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, shares issued |
|
40,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate gross proceeds from ordinary shares | $ |
|
$ 46,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from registered direct offerings, net of transaction costs | $ |
|
$ 42,100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional ordinary shares that can be purchased by underwriter |
|
5,217,391
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of ordinary shares issued to purchase warrants |
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February Underwritten Offering | Pursuant to the Underwriting Agreement | Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
2,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
$ 1.4375
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement | Securities Purchase Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
|
|
208,023
|
|
|
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
|
|
|
|
|
|
|
$ 2.1031
|
$ 1.62
|
|
|
|
|
|
|
|
Warrants expiry date |
|
|
|
|
|
|
|
|
Jun. 03, 2025
|
Dec. 05, 2025
|
|
|
|
|
|
|
|
Percentage of ordinary shares issued to purchase warrants |
|
|
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
Private Placement | Securities Purchase Agreement | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
|
|
|
1,485,885
|
|
|
|
|
|
|
|
Private Placement | June 30 SPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from registered direct offerings, net of transaction costs | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,800
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
|
236,088
|
|
|
|
1,264,757
|
1,264,757
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
|
|
|
|
|
|
$ 1.8531
|
|
|
$ 1.42
|
|
|
|
|
|
|
Warrants expiry date |
|
|
|
|
|
|
|
Jun. 30, 2025
|
|
|
Jan. 02, 2026
|
|
|
|
|
|
|
Percentage of ordinary shares issued to purchase warrants |
|
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
Private Placement | June 30 SPA | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
|
|
|
|
1,686,343
|
|
|
|
|
|
|
Private Placement | Exchangeable Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate principal amount of exchangeable notes | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 39,200
|
|
|
|
|
|
Private Placement | June 3 SPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants closing date |
|
|
|
|
|
|
|
|
|
Jun. 05, 2020
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
|
|
208,023
|
|
|
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
|
|
|
|
|
|
|
|
$ 2.1031
|
$ 1.62
|
|
|
|
|
|
|
|
Warrants expiry date |
|
|
|
|
|
|
|
|
Jun. 03, 2025
|
Dec. 05, 2025
|
|
|
|
|
|
|
|
Percentage of ordinary shares issued to purchase warrants |
|
|
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
Private Placement | June 3 SPA | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
|
|
|
|
|
|
|
|
|
1,485,885
|
|
|
|
|
|
|
|
February Registered Direct Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase ordinary shares, exercise price | $ / shares |
$ 2.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering closing date |
Feb. 12, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiry date |
Feb. 09, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of ordinary shares issued to purchase warrants |
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February Registered Direct Offering | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants to purchase ordinary shares |
1,225,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|